Search

Issue
Title
Authors
An interdisciplinary approach to the management of oncohematological patients with immunodeficiency: clinical cases. A review
Babicheva L.G., Luntsov A.V., Khusainova G.N., Poddubnaya I.V.
Innovations in the therapy of oncohematological diseases
Editorial B.
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem The results of the project with the discussion concerning the possibility of optimization approaches for the therapy
Editorial B.
Pharmacoeconomic analysis of acalabrutinib in patients with chronic lymphocytic leukemia
Nedogoda S.V., Salasyuk A.S., Barykina I.N., Lutova V.O., Popova E.A.
Acalabrutinib in the treatment of chronic lymphocytic leukemia: a review of recent evidence
Petrenko A.A., Kislova M.I., Dmitrieva E.A., Nikitin E.A.
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Nikitin E.A., Bialik T.E., Zaritskii A.I., Iseber L., Kaplanov K.D., Lopatkina T.N., Lugovskaia S.A., Mukhortova O.V., Osmanov E.A., Poddubnaya I.V., Samoilova O.S., Stadnik E.A., Falaleeva N.A., Baikov V.V., Kovrigina A.M., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I.V., Al-Radi L.S., Byalik T.E., Kaplanov K.D., Molostvova V.Z., Nikitin E.A., Pospelova T.I., Ptushkin V.V., Samoilova O.S., Stadnik E.A., Tumyan G.S.
Prospective analysis of efficacy and safety of BR regime in the first-line treatment of chronic lymphocytic leukemia
Stadnik E.A., Strugov V.V., Andreeva T.O., Virts Y.V., Mirolyubova Y.V., Butylin P.A., Zaritskiy A.Y.
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I.V., Bialik T.E., Glonina N.N., Kalashnikova O.B., Kaplanov K.D., Lapin V.A., Medvedeva N.V., Mikhailova N.B., Moiseeva T.N., Nikitin E.A., Pospelova T.I., Stadnik E.A.
Current treatment of chronic lymphocytic leukemia. New opportunities and new difficulties
Samoylova O.S.
Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia
Mirolyubova Y.V., Stadnik E.A.
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia
Bialik T.E., Vorob'ev V.I., Ionin V.A., Ysebaert L., Kaplanov K.D., Mendeleeva L.P., Nikitin E.A., Ptushkin V.V., Samoilova O.S., Stadnik E.A.
Regulatory T-cells (Treg) in lymphoproliferative diseases
Kuzmina E.G., Mushkarina T.Y., Konstantinova T.V.
1 - 13 of 13 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies